glycosylated fibronectin

Also Known As:
fibronectin, glycosylated; glycated fibronectin
Networked: 7 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results


1. Roberts, Charles T: 2 articles (01/2015 - 09/2013)
2. Gravett, Michael G: 2 articles (01/2015 - 09/2013)
3. Nagalla, Srinivasa R: 2 articles (01/2015 - 09/2013)
4. Bean, Eric: 1 article (01/2015)
5. Laurie, Amber: 1 article (01/2015)
6. Rasanen, Juha: 1 article (01/2015)
7. Quinn, Matthew J: 1 article (01/2015)
8. Snyder, Caryn K: 1 article (09/2013)
9. Rasanen, Juha P: 1 article (09/2013)
10. Mihalache, Raluca: 1 article (09/2013)

Related Diseases

1. Fibroma (Fibromatosis)
12/01/1995 - "The spatial correlation of myofibroblast phenotype, TGF beta and bFGF synthesis and the occurrence of the oncofetal molecular fibronectin variants (ED-B+ and oncofetal glycosylated fibronectin) in the active proliferative fibromatosis nodules suggests a pathogentic role of these growth factors and matrix components in the tumorous tissue formation process. "
11/01/1995 - "Differential expression of fibronectin splice variants, oncofetal glycosylated fibronectin and laminin isoforms in nodular palmar fibromatosis."
11/01/1995 - "The tissue formation process in nodular palmar fibromatosis (Morbus Dupuytren) was investigated by the demonstration of fibronectin splice variants (ED-A and ED-B fibronectin), de novo glycosylated fibronectin and laminin isoforms (A, M, B1, B2, s chains) in association to the proliferative activity (Ki-67 antigen) and the occurrence of myofibroblast phenotype (alpha-smooth muscle actin, desmin). "
12/01/1995 - "To investigate a possible implication of these growth factors in the tissue formation process of palmar fibromatosis, TGF beta 1/2 and bFGF synthesis, as well as TGF beta 1/3 and bFGF tissue distribution, is demonstrated by RNA in situ hybridization and/or immunohistochemistry in relation to myofibroblast phenotype development (alpha-smooth muscle actin, desmin immunohistochemistry), expression of different fibronectin isoforms (ED-A+, ED-B+ and oncofetal glycosylated fibronectin immunohistochemistry, fibronectin RNA in situ hybridization) and cellular activity (cyclin RNA in situ hybridization, Ki-67 immunolabelling). "
2. Carcinoma (Carcinomatosis)
3. Gestational Diabetes (Gestational Diabetes Mellitus)
4. Pre-Eclampsia (Preeclampsia)
5. Osteoarthritis

Related Drugs and Biologics

1. Fibronectins (Fibronectin)
2. Protein Isoforms (Isoforms)
3. Desmin
4. Transforming Growth Factor beta1 (TGF beta 1)
5. Intercellular Signaling Peptides and Proteins (Growth Factors)
6. Cyclins
7. Transforming Growth Factor beta (TGF-beta)
8. RNA (Ribonucleic Acid)
9. Laminin (Merosin)